AzTrials
AzTrials

HypnosisHypnoanxietyNCT07370974

Effect of Clinical Hypnosis in Preoperative Anxiety Among Patients Undergoing an Abdominal Surgery.

A study testing Clincal hypnosis in people with Hypnosis and Preoperative Anxiety, run by HASSAN 1st university at 3 sites in Morocco.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This Multicenter randomized controlled trial evaluates clinical hypnosis efficacy for reducing perioperative anxiety and postoperative pain in abdominal surgery patients across 3 Moroccan centers (n=48-68). Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Hypnosis, Preoperative Anxiety, Postoperative Pain
What is being tested?
Clincal hypnosis
Could I receive a placebo?
No, everyone receives an active treatment
How many people
48 participants
Where
3 sitesMorocco
Study dates
7 Feb 2026to 3 Jun 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Consenting patients undergoing abdominal surgery
  • ASA I-II physical status
  • Able to understand and respond to instructions
  • No major psychological disorders

Who cannot join

  • Non-consenting patients
  • Prior experience with hypnosis
  • History of mental illness
  • Psychoactive substance consumption
  • Cognitive disorders

Trial locations and contacts

3 sites in 1 country.

Morocco3 sites
  • Kenitra, Rabat Sale Kenitra region, Morocco

    Kenitra, Province, 14000

  • Settat, Casablanca settat region , Morocco

    Settat, Province, 26000

  • Youssoufia, Marrakech-Safi Morocco

    Youssoufia, Province, 46300

Other trials in Morocco

About this study

Official title: Effect of Clinical Hypnosis in Preoperative Anxiety Among Patients Undergoing an Abdominal Surgery : a Multicenter Randomized Controlled Trial.

This Multicenter randomized controlled trial evaluates clinical hypnosis efficacy for reducing perioperative anxiety and postoperative pain in abdominal surgery patients across 3 Moroccan centers (n=48-68). Intervention arm receives 15-20 min level 2 hypnosis session preoperatively; control receives standard psychological preparation. Primary outcome: VAS-anxiety post-intervention. Secondary: postoperative EVA-pain, analgesic consumption, length of stay.

Study Design Prospective, multicenter, parallel-group RCT (1:1 allocation, stratified by center/sex). Inclusion: consenting ASA I-II adults for abdominal surgery. Primary endpoint powered for 10mm EVA reduction (80% power, α=0.05). Registration supports PhD thesis at ISSS/Université Hassan 1er Settat.

Being tested
Clincal hypnosis
Keywords
RCT, Morocco, Hypnosis, preoperative anxiety
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Clincal hypnosisOther

    Also called Hypnosis, hypnotism, Hypnosis session

    Patients randomized to the intervention arm receive a single 15-20 minute individual clinical hypnosis session 30-60 minutes preoperatively. The standardized protocol includes:

    • Induction phase (3-5 min): Eye fixation, progressive relaxation breathing
    • Deepening phase (5 min): Level 2 somnambulistic trance achievement
    • Therapeutic suggestions (7-10 min): Anxiety reduction imagery, surgical calm visualization
    • Emergence phase (2-3 min): Safe awakening to alert consciousness

    Delivered by certified hypnotherapist using validated script for preoperative anxiety in abdominal surgery patients." Key Elements Required Timing: Preop holding area, 30-60 min before incision Provider: Trained clinician (specify certification) Dose: Single 15-20 min session Target: Level 2 hypnosis (somnambulism) Outcome link: EVA anxiety scale pre/post This matches your 3-center RCT design (~16 patients/center, stratified randomization) and distinguishes from control arm (standard psychological preparation

Study groups in NCT07370974
Study groupRoleWhat they receive
Fisrt arm: patients having a session of hypnosis prior to surgeryExperimentalPatients randomized to the intervention arm undergo a single 15-20 minute clinical hypnosis session preoperatively for anxiety reduction, achieving level 2 hypnotic trance (somnambulism)
Receives: Other: Clincal hypnosis
Arm 2 : patients will be treated as usual with standard conditionsNo interventionPatients in this group will receive standard usual care without any hypnotic intervention, only with routine psychological preparation.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Preoperative anxiety

    Perioperative Anxiety (Primary Outcome) is measured using the Visual Analog Scale for Anxiety (EVA-Anxiété, 0-100 mm).

    Primary Outcome Measure: preoperative anxiety level

    Assessment Tool: 100-mm Visual Analog Scale (VAS-Anxiety):

    0 mm = No anxiety ("Je ne suis pas du tout anxieux") 100 mm = Worst possible anxiety ("Anxiété maximale imaginable") Timepoints: (post-intervention, ~10 min later). Expected hypnosis effect: ≥10 mm reduction vs. control.

    Protocol Specifications Patient marking: Single horizontal 100-mm line; mark position indicates intensity Scoring: Distance (mm) from "No anxiety" (0) to mark, precise to 1 mm

    Measured: 1 hour Before surgery

Secondary outcomes (3)
  1. Postoperative pain

    Secondary Outcome Measure: Acute postoperative pain intensity at 6, and 24 hours post-surgery.

    Assessment Tool: 100-mm VAS-Pain Scale:

    0 mm = No pain ("Aucune douleur") 100 mm = Worst imaginable pain ("Douleur maximale imaginable") Timepoints: T+6h, T+24h. Expected hypnosis benefit: ≥10 mm reduction vs. control .

    Protocol Specifications Patient marking: Horizontal 100-mm line; precise mm measurement from 0 Analgesia standardization: Multimodal protocol identical across arms (paracetamol, NSAIDs, opioids rescue) Power: Secondary analysis leverages primary outcome sample (48-68 patients, 80% power for Δ=10 mm, σ=24 mm)

    ClinicalTrials.gov Entry: "Postoperative pain intensity measured by 100-mm Visual Analog Scale at rest in PACU at 1, 2, 6, and 24 hours post-surgery"

    This complements your prim

    Measured: 6 and 24 hours postoperatively

  2. medication consumption

    Secondary Outcome Measure: Anesthia drugs consumption and postoperative consumption of analgesics (morphine equivalents, paracetamol, NSAIDs, opioids) from PACU arrival to discharge.

    Assessment Method:

    Total mg/doses per patient, Data collection: Medication administration records (MAR), nurse logs Expected hypnosis effect: ≥20-30% reduction vs. control arm. Protocol Specifications

    Standardized multimodal analgesia (identical both arms):

    Measured: Perioperative

  3. length of stay

    Secondary Outcome Measure: Time to hospital discharge (days) from surgery day (Day 0) to medical discharge order date.

    Assessment Method:

    Calendar days: Date of discharge hour date of surgery Expected hypnosis effect: ≥1 day reduction vs. control (typical LOS 3-5 days abdominal surgery).

    Protocol Specifications

    Standardized discharge criteria (identical both arms):

    Tolerates solid diet VAS-pain ≤30 mm at rest Mobilizes independently to bathroom Afebrile, normal vital signs Data collection: medical record discharge order timestamp

    Measured: Perioperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jan 2026
  2. Study start7 Feb 2026
  3. Primary completion20 Mar 2026
  4. Study completion3 Jun 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
48 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07370974
Sponsor's protocol ID
Hypnosis UHP
Acronym
Hypnoanxiety
Status last verified
Sep 2026
First submitted
2 Jan 2026
Last updated
11 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Data sharing not planned. Individual patient data will not be shared due to:" Small sample size (n=60 across 3 centers) creates high re-identification risk in Morocco's healthcare context Patient consent forms obtained pre-NIH Policy 2.0 did not include data sharing provisions Doctoral thesis protocol approved by CERB Mohammed V Rabat without data sharing plan Local data protection regulations (Loi 28-13) limit identifiable health data transfer Resource constraints prevent data de-identification and controlled access infrastructure Summary results, statistical analysis plan, and blinded protocol available upon request to corresponding author post-publication.

Questions about this trial

What is this clinical trial studying?

A study testing Clincal hypnosis in people with Hypnosis and Preoperative Anxiety, run by HASSAN 1st university at 3 sites in Morocco.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Morocco. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Preoperative anxiety (time frame: 1 hour Before surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in